New CDC recommendations for HIV testing in laboratories : a step-by-step account of the approach by Centers for Disease Control and Prevention (U.S.)
CDC’s new recommendations for HIV testing in laboratories capitalize on the latest available technologies to help diagnose HIV infections earlier – as much as 3-4 weeks sooner 
than the previous testing approach. Early diagnosis is critical since many new infections are transmitted by people in the earliest (“acute”) stage of infection. 
By putting the latest testing technology to work in laboratories across the United States, we can help address a critical gap in the nation’s HIV prevention e orts.
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Step 1: “Fourth generation” 
HIV test
Detecting HIV sooner
Detects HIV in the blood earlier than 
previously recommended antibody tests 
by identifying the HIV-1 p24 antigen, a 
viral protein which appears in the blood 

















Step 3: Nucleic Acid Test (NAT)
Acute HIV-1 infection or “false positive”?
Ensures accurate detection of early infection or indicates 
a false positive from the fourth generation test.
Step 2: HIV-1/HIV-2 antibody 
di erentiation immunoassay
Diagnosing HIV-1 vs. HIV-2
Produces results faster than the previously 
recommended Western Blot.
Distinguishes between HIV-1 and HIV-2, which the 
previously recommended Western Blot cannot 
do – this distinction can have important treatment 
implications for a patient.
This graphic is designed to illustrate key concepts of the new testing approach in laboratories. For more detail, please see the full guidelines here: 
http://www.cdc.gov/hiv/pdf/HIVtestingAlgorithmRecommendation-Final.pdf.
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